In vitro cytotoxicity testing of non-thiolated and thiolated chitosan nanoparticles for oral gene delivery

Nanotoxicology

Volumn 1, Issue 2, 2007, Pages 139-148

  Loretz, Brigitta ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Caco 2; Chitosan NAC; Thiomer; Toxicology; Transfection; Zeta potential

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLCYSTEINE; CHITOSAN; LACTATE DEHYDROGENASE; NANOPARTICLE; PLASMID DNA; POLYMER; THIOL DERIVATIVE;

ANTIGEN ANTIBODY REACTION; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; ELECTRIC RESISTANCE; ERYTHROCYTE; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE DAMAGE; MITOCHONDRION; PARTICLE SIZE; PH; PRIORITY JOURNAL; TOXICITY TESTING; ZETA POTENTIAL;

EID: 34548324792     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.1080/17435390701554200     Document Type: Article

References (26)

1. Akgun E, Caliskan C, Celik HA, Ozutemiz AO, Tuncyurek M, Aydin HH. 2005. Effects of N-acetylcysteine treatment on oxidative stress in acetic acid-induced experimental colitis in rats. J Int Med Res 33(2):196-206.
2. Chambers E, Mitragotri S. 2004. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. J Control Release 100(1):111-119.
3. Chen J, Yang WL, Li G, Qian J, Xue JL, Fu SK, Lu DR. 2004. Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J Gastroenterol 10(1):112-116.
4. Dekie L, Toncheva V, Dubruel P, Schacht EH, Barrett L, Seymour LW. 2000. Poly-L-glutamic acid derivatives as vectors for gene therapy. J Control Release 65(1-2):187-202.
5. Florence AT, Hussain N. 2001. Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas. Adv Drug Deliv Rev 50(Suppl. 1):S69-89.
6. Giles J. 2004. Size matters when it comes to safety, report warns. Nature 430(7000):599.
7. Goodman CM, McCusker CD, Yilmaz T, Rotello VM. 2004. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15(4):897-900.
8. Guggi D, Langoth N, Hoffer MH, Wirth M, Bernkop-Schnurch A. 2004. Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate. Int J Pharm 278(2):353-360.
9. Hoet PH, Bruske-Hohlfeld I, Salata OV. 2004. Nanoparticles - known and unknown health risks. J Nanobiotechnology 2(1):12.
10. Hornof MD, Kast CE, Bernkop-Schnurch A. 2003. In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Eur J Pharm Biopharm 55(2):185-190.
11. Huang M, Khor E, Lim LY. 2004. Uptake and cytotoxicity of chitosan molecules and nanoparticles: Effects of molecular weight and degree of deacetylation. Pharm Res 21(2):344-353.
12. Jani P, Halbert GW, Langridge J, Florence AT. 1990. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J Pharm Pharmacol 42(12):821-826.
13. Lee D, Zhang W, Shirley SA, Kong X, Hellermann GR, Lockey RF, Mohapatra SS. 2007. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res 24(1):157-167.
14. Lee KY, Ha WS, Park WH. 1995. Blood compatibility and biodegradability of partially N-acylated chitosan derivatives. Biomaterials 16(16):1211-1216.
15. Leitner VM, Walker GF, Bernkop-Schnurch A. 2003. Thiolated polymers: Evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm 56(2):207-214.
16. Loretz B, Thaler M, Bernkop-Schnürch A. 2007. Role of sulfhydryl goups in transfection? A case study with chitosan-NAC nanoparticles. Bioconjug Chem 18(4):1028-1035.
17. MacLaughlin FC, Mumper RJ, Wang J, Tagliaferri JM, Gill I, Hinchcliffe M, Rolland AP. 1998. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 56(1-3):259-272.
18. Martien R, Loretz B, Thaler M, Majzoob S, Bernkop-Schnurch A. 2007. Chitosan-thioglycolic acid conjugate: An alternative carrier for oral nonviral gene delivery? J Biomed Mater Res A 82A(1):1-9.
19. Nimesh S, Kumar R, Chandra R. 2006. Novel polyallylamine-dextran sulfate-DNA nanoplexes: Highly efficient non-viral vector for gene delivery. Int J Pharm 320(1-2):143-149.
20. Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, et al. 2005. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8.
21. Qi L, Xu Z, Jiang X, Li Y, Wang M. 2005. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg Med Chem Lett 15(5):1397-1399.
22. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. 2004. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377(Pt 1):159-169.
23. Roy K, Mao HQ, Huang SK, Leong KW. 1999. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 5(4):387-391.
24. Sambruy Y, Ferruzza S, Ranaldi G, De Angelis I. 2001. Intestinal cell culture models: Applications in toxicology and pharmacology. Cell Biol Toxicol 17(4-5):301-317.
25. Yin H, Too HP, Chow GM. 2005. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 26(29):5818-5826.
26. Zheng F, Shi XW, Yang GF, Gong LL, Yuan HY, Cui YJ, Wang Y, Du YM, Li Y. 2007. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: Results of an in vitro and in vivo study. Life Sci 80(4):388-396.